Home LiteratureArticle Details
PMID: 89089 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Antigenic specificity of neutralizing antibody to cholera toxin.

Infection and immunity ·Vol. 24 ·No. 3 ·1979-06-00 ·Pages 774-9

Peterson JW, Hejtmancik KE, Markel DE, Craig JP, Kurosky A

Abstract

Selected rabbit antisera to cholera toxin antigens and convalescent cholera patient sera were analyzed using the permeability factor neutralization test and two sensitive in vitro serological assays specific for cholera toxin, cholera toxin A subunit, and cholera toxin B subunit. The results indicated that antisera to cholera toxin contained toxin-neutralizing activity as well as antibodies specific for both the A subunit and B subunit. It was clearly established that antisera to B subunit, devoid of significant anti-A subunit activity, neutralized the vascular permeability activity of cholera toxin. Antisera to A subunit contained neutralizing antibodies and antibodies to both A and B subunits. Absorption with B subunit removed both the toxin-neutralizing and anti-B subunit activities, while the anti-A activity was unaffected. Neutralizing antibody titers of rabbits immunized with B subunit were also observed to be significantly higher than neutralizing antibody titers of sera from A subunit-immunized rabbits, despite the overall similarity in anti-B subunit titers as determined by passive hemagglutination and radioimmunoassay of sera from the two groups of rabbits. Anti-alpha chain sera neither neutralized cholera toxin nor possessed significant antitoxin or anti-B subunit titers as determined by passive hemagglutination and radioimmunoassay. The anti-alpha chain sera contained high levels of antibody specific for A subunit, which is consistent with the hypothesis that the alpha chain is part of the A subunit structure. In contrast, the gamma chain was not shown to be antigenic. Sera from convalescent cholera patients possessed toxin-neutralizing antibody as well as passive hemagglutination and radioimmunoassay antibody against both A and B subunits.

MeSH Terms
Animals Antitoxins/immunology Cholera/immunology Cholera Toxin/immunology Epitopes Hemagglutination Tests Humans Immunization Neutralization Tests Rabbits Radioimmunoassay
Chemicals
Antitoxins Epitopes Cholera Toxin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Peterson J W
Hejtmancik K E
Markel D E
Craig J P
Kurosky A
References (7)
7 references, click to expand
  1. Radioimmunoassay for the antigenic determinants of cholera toxin and its components.
    Infect Immun. 1977 Sep;17(3):621-8 PMID: 71268
  2. Development of improved cholera vaccine based on subunit toxoid.
    Nature. 1977 Oct 13;269(5629):602-4 PMID: 72361
  3. Structure, function, and antigenicity of cholera toxin.
    J Supramol Struct. 1979;10(2):137-49 PMID: 88548
  4. Covalent structure of the beta chain of cholera enterotoxin.
    J Biol Chem. 1977 Oct 25;252(20):7257-64 PMID: 903363
  5. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
    Infect Immun. 1974 Feb;9(2):304-17 PMID: 4205946
  6. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.
    Nature. 1965 Aug 7;207(997):614-6 PMID: 5883637
  7. In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals.
    Infect Immun. 1970 Jan;1(1):21-9 PMID: 16557689
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1979-06-00
Pages
774-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC414373
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]